Literature DB >> 25689717

G protein coupled receptor 50 promotes self-renewal and neuronal differentiation of embryonic neural progenitor cells through regulation of notch and wnt/β-catenin signalings.

Yan-Xia Ma1, Zhi-Qiang Wu1, Yong-Jie Feng1, Zhi-Cheng Xiao2, Xiao-ling Qin3, Quan-Hong Ma4.   

Abstract

G protein-coupled receptor 50 (GPR50), a risk factor for major depressive disorder and bipolar affective disorder, is expressed in both the developmental and adult brain. However, the function of GPR50 in the brain remains unknown. We here show GPR50 is expressed by neural progenitor cells (NPCs) in the ventricular zone of embryonic brain. Knockdown of GPR50 with a small interference RNA (siRNA) decreased self-renewal and neuronal differentiation, but not glial differentiation of NPCs. Moreover, overexpression of either full-length GPR50 or the intracellular domain of GPR50, rather than the truncated GPR50 in which the intracellular domain is deleted in, increased neuronal differentiation, indicating that GPR50 promotes neuronal differentiation of NPCs in an intracellular domain-dependent manner. We further described that the transcriptional activity of the intracellular domain of notch on Hes1 gene was repressed by overexpression of GPR50. In addition, decreased levels of transcription factor 7-like 2 (TCF7L2) mRNA was observed in GPR50 siRNA-transfected NPCs, suggesting that knockdown of GPR50 impairs wnt/β-catenin signaling. Moreover, the mRNA levels of neurogenin (Ngn) 1, Ngn2 and cyclin D1, the target genes of notch and wnt/β-catenin signalings, in NPCs were reduced by knockdown of GPR50. Therefore, GPR50 promotes self-renewal and neuronal differentiation of NPCs possibly through regulation of notch and wnt/β-catenin signalings.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differentiation; GPR50; NPCs; Notch; Self-renewal; Wnt/β-catenin

Mesh:

Substances:

Year:  2015        PMID: 25689717     DOI: 10.1016/j.bbrc.2015.02.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.

Authors:  Muhammad Zahid Khan; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2017-03-13       Impact factor: 4.530

2.  ERK-dependent induction of the immediate-early gene Egr1 and the late gene Gpr50 contribute to two distinct phases of PACAP Gs-GPCR signaling for neuritogenesis.

Authors:  Wenqin Xu; Sam P Dahlke; Michelle Sung; Babru Samal; Andrew C Emery; Abdel Elkahloun; Lee E Eiden
Journal:  J Neuroendocrinol       Date:  2022-07-16       Impact factor: 3.870

3.  Integrated genetic, epigenetic, and gene set enrichment analyses identify NOTCH as a potential mediator for PTSD risk after trauma: Results from two independent African cohorts.

Authors:  Daniela Conrad; Sarah Wilker; Anna Schneider; Alexander Karabatsiakis; Anett Pfeiffer; Stephan Kolassa; Virginie Freytag; Vanja Vukojevic; Christian Vogler; Annette Milnik; Andreas Papassotiropoulos; Dominique J-F de Quervain; Thomas Elbert; Iris-Tatjana Kolassa
Journal:  Psychophysiology       Date:  2018-10-17       Impact factor: 4.016

4.  Significant association between GPR50 hypomethylation and AD in males.

Authors:  Weihua Chen; Huihui Ji; Liping Li; Chunshuang Xu; Ting Zou; Wei Cui; Shujun Xu; Xiaohui Zhou; Shiwei Duan; Qinwen Wang
Journal:  Mol Med Rep       Date:  2019-06-06       Impact factor: 2.952

Review 5.  Hypothalamic Wnt Signalling and its Role in Energy Balance Regulation.

Authors:  G Helfer; A Tups
Journal:  J Neuroendocrinol       Date:  2016-03       Impact factor: 3.627

6.  Impact of siRNA targeting of β-catenin on differentiation of rat neural stem cells and gene expression of Ngn1 and BMP4 following in vitro hypoxic-ischemic brain damage.

Authors:  Xiaoying Zhang; Cuicui Zhu; Qiong Luo; Jv Dong; Lv Liu; Min Li; Hongtao Zhu; Xiangping Ma; Jun Wang
Journal:  Mol Med Rep       Date:  2016-08-24       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.